Coronavirus vaccine development: from SARS and MERS to COVID-19 - Journal of Biomedical Science

Clicks: 127
ID: 273553
2020
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new type of coronavirus that causes the Coronavirus Disease 2019 (COVID-19), which has been the most challenging pandemic in this century. Considering its high mortality and rapid spread, an effective vaccine is urgently needed to control this pandemic. As a result, the academia, industry, and government sectors are working tightly together to develop and test a variety of vaccines at an unprecedented pace. In this review, we outline the essential coronavirus biological characteristics that are important for vaccine design. In addition, we summarize key takeaways from previous vaccination studies of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV), highlighting the pros and cons of each immunization strategy. Finally, based on these prior vaccination experiences, we discuss recent progress and potential challenges of COVID-19 vaccine development.
Reference Key
yen-der2020journalcoronavirus Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Li, Yen-Der;Chi, Wei-Yu;Su, Jun-Han;Ferrall, Louise;Hung, Chien-Fu;Wu, T.-C.;Li, Yen-Der;Chi, Wei-Yu;Su, Jun-Han;Ferrall, Louise;Hung, Chien-Fu;Wu, T.-C.;
Journal journal of biomedical science
Year 2020
DOI doi:10.1186/s12929-020-00695-2
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.